Product Website: www.targrissohcp.com Production Information: For patients with metastatic EGFR T790 mutation positive NSCLC as detected by an FDA approved test, a progression on or after TKI therapy. NDC Code: 00310-1350-30 80 mg 30 count Companion Diagnostic: YES REMs: NO |
Limited Distribution: YES Manufacturer Reimbursement Assistance: Patient Assistance (844) 275-2360 or www.myaccess360.com. If there are financial barriers to fulfilling this prescription, www.astrazeneca-us.com/medicines/Affordability.html may be able to help. |
Online Information:
Direct to patient nurse/clinical support program:
Additional products/supplies for patients: |
Professional educational materials available from your sales specialist: Online Information: |
To identify or connect with your specialist please contact:
Brian Jenkins
614-596-1298